HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orson W Moe Selected Research

Ammonium Compounds

11/2020Uric Acid and Urate in Urolithiasis: The Innocent Bystander, Instigator, and Perpetrator.
1/2019Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
1/2019Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
11/2013Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
7/2010Metabolic basis for low urine pH in type 2 diabetes.
11/2009Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification.
6/2008Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion.
5/2006Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
2/2004The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
12/2002Pathophysiology of uric acid nephrolithiasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Orson W Moe Research Topics

Disease

31Nephrolithiasis
01/2019 - 09/2002
18Chronic Renal Insufficiency
07/2021 - 11/2010
17Kidney Calculi (Kidney Stone)
01/2021 - 11/2002
16Hypercalciuria
12/2018 - 12/2003
14Acute Kidney Injury (Acute Renal Failure)
01/2022 - 11/2010
13Fibrosis (Cirrhosis)
01/2022 - 01/2013
12Acidosis
09/2021 - 07/2002
9Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019 - 02/2004
8Kidney Diseases (Kidney Disease)
07/2021 - 12/2012
7Hyperphosphatemia
02/2019 - 01/2010
6Reperfusion Injury
01/2022 - 12/2010
6Hypertension (High Blood Pressure)
02/2019 - 09/2002
6Familial Hypophosphatemia (Phosphate Diabetes)
12/2012 - 04/2005
5Urolithiasis
11/2020 - 07/2010
5Chronic Kidney Failure (Chronic Renal Failure)
06/2019 - 09/2002
5Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
01/2018 - 11/2014
5Insulin Resistance
01/2018 - 12/2002
5Vascular Calcification
07/2014 - 01/2011
4Hypophosphatemia
12/2021 - 02/2005
4Hyperoxia
10/2021 - 10/2014
4Inflammation (Inflammations)
01/2021 - 12/2012
4Hypertrophy
01/2021 - 11/2011
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2018
4Obesity
12/2019 - 01/2014
4Type 2 Diabetes Mellitus (MODY)
11/2013 - 05/2006
3Sepsis (Septicemia)
01/2022 - 12/2019
3Critical Illness (Critically Ill)
01/2022 - 01/2021
3Renal Insufficiency (Renal Failure)
07/2021 - 09/2002
3Hyperoxaluria (Oxaluria)
01/2018 - 10/2012
3Gout
01/2018 - 12/2011
3Hypercalcemia (Milk Alkali Syndrome)
01/2017 - 10/2014
3Edema (Dropsy)
04/2016 - 10/2014
3Cardiomegaly (Heart Hypertrophy)
06/2015 - 01/2013
3Bone Resorption
11/2009 - 12/2003
2Neoplasms (Cancer)
01/2022 - 12/2011
2Cardiomyopathies (Cardiomyopathy)
01/2021 - 01/2017
2Body Weight (Weight, Body)
12/2019 - 05/2006
2Albuminuria
06/2019 - 02/2013
2Hyperparathyroidism
02/2019 - 03/2013
2Urinary Calculi (Urinary Calculus)
12/2018 - 11/2004
2Ischemia
04/2016 - 10/2011
2Hyperuricemia
06/2015 - 11/2012
2Hyperaldosteronism (Conn Syndrome)
10/2014 - 07/2004
2Diarrhea
10/2012 - 12/2011

Drug/Important Bio-Agent (IBA)

24Uric Acid (Urate)IBA
11/2020 - 09/2002
22Phosphates (Orthophosphate)IBA
01/2022 - 02/2005
15AcidsIBA
01/2021 - 07/2002
15CalciumIBA
11/2020 - 07/2004
14Citric Acid (Citrate)FDA LinkGeneric
01/2021 - 02/2004
13Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2010
13Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2003
11CreatinineIBA
01/2022 - 09/2007
10Ammonium CompoundsIBA
11/2020 - 12/2002
8Fibroblast Growth Factor-23IBA
12/2021 - 03/2006
8Calcium OxalateIBA
11/2020 - 02/2004
7AlkaliesIBA
09/2021 - 01/2003
7SaltsIBA
11/2020 - 09/2002
5calcium phosphateIBA
01/2021 - 10/2006
5MineralsIBA
01/2018 - 11/2009
4OxalatesIBA
01/2021 - 10/2012
4BuffersIBA
11/2020 - 11/2009
4Vitamin DFDA LinkGeneric
01/2020 - 02/2005
4AnionsIBA
01/2019 - 12/2003
4Glucose (Dextrose)FDA LinkGeneric
01/2019 - 02/2004
4LipidsIBA
04/2016 - 11/2009
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2014
3Beclin-1IBA
01/2022 - 01/2018
3Parathyroid Hormone (Parathormone)IBA
12/2021 - 04/2005
3DNA (Deoxyribonucleic Acid)IBA
10/2021 - 04/2016
3Potassium CitrateFDA LinkGeneric
01/2021 - 01/2003
3Protons (Proton)IBA
01/2019 - 07/2006
3Hormones (Hormone)IBA
01/2019 - 03/2006
3AmmoniaIBA
01/2019 - 02/2004
3dirhodium tetraacetate (DRTA)IBA
01/2018 - 01/2016
3PotassiumIBA
09/2017 - 01/2003
3SodiumIBA
10/2013 - 10/2011
3Insulin (Novolin)FDA Link
07/2011 - 09/2002
2Peptides (Polypeptides)IBA
01/2022 - 01/2010
2ReninIBA
08/2021 - 02/2019
2Bicarbonates (Hydrogen Carbonate)IBA
01/2021 - 12/2002
2Fatty Acids (Saturated Fatty Acids)IBA
12/2019 - 01/2019
2fibroblast growth factor 21IBA
06/2019 - 06/2018
2Succinic Acid (Succinate)IBA
02/2019 - 10/2013
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
01/2018 - 04/2016
2Biological ProductsIBA
01/2018 - 02/2015
2AntioxidantsIBA
01/2018 - 01/2013
2hydroxide ionIBA
01/2018 - 02/2005
2MagnesiumIBA
01/2018 - 08/2008
2Estrogens (Estrogen)FDA Link
01/2017 - 11/2002
2AdiponectinIBA
01/2017 - 02/2013
2Conditioned Culture MediaIBA
04/2016 - 10/2014
2Adenosine Triphosphatases (ATPase)IBA
11/2014 - 04/2005
2Triglycerides (Triacylglycerol)IBA
01/2014 - 09/2007
2Messenger RNA (mRNA)IBA
10/2011 - 08/2007
2Phosphate Transport Proteins (Phosphate Transporter)IBA
08/2011 - 09/2010
2Topiramate (Topamax)FDA LinkGeneric
08/2011 - 10/2006
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
02/2011 - 01/2003

Therapy/Procedure

12Therapeutics
09/2021 - 09/2002
3Nephrectomy
01/2017 - 01/2014
2Artificial Respiration (Mechanical Ventilation)
01/2022 - 01/2019